Inhibition of Transmural Inflammation in Crohn's Disease by Orally Administered Tumor Necrosis Factor-Alpha Deoxyribozymes-Loaded Pyroptosis Nanoinhibitors.

MLA

Li, Zhun, et al. “Inhibition of Transmural Inflammation in Crohn’s Disease by Orally Administered Tumor Necrosis Factor-Alpha Deoxyribozymes-Loaded Pyroptosis Nanoinhibitors.” ACS Applied Materials & Interfaces, vol. 16, no. 31, Aug. 2024, pp. 40499–514. EBSCOhost, https://doi.org/10.1021/acsami.4c05921.

APA

Li, Z., Zhu, Z., Zhou, D., Chen, Y., Yin, Y., Zhang, Z., Yang, J., Gao, Y., Zhu, W., Song, Y., & Li, Y. (2024). Inhibition of Transmural Inflammation in Crohn’s Disease by Orally Administered Tumor Necrosis Factor-Alpha Deoxyribozymes-Loaded Pyroptosis Nanoinhibitors. ACS Applied Materials & Interfaces, 16(31), 40499–40514. https://doi.org/10.1021/acsami.4c05921

Chicago

Li, Zhun, Zhenxing Zhu, Dongtao Zhou, Yusheng Chen, Yi Yin, Zhibin Zhang, Jingjing Yang, et al. 2024. “Inhibition of Transmural Inflammation in Crohn’s Disease by Orally Administered Tumor Necrosis Factor-Alpha Deoxyribozymes-Loaded Pyroptosis Nanoinhibitors.” ACS Applied Materials & Interfaces 16 (31): 40499–514. doi:10.1021/acsami.4c05921.